Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans
- PMID: 15741263
- DOI: 10.1210/jc.2004-1953
Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans
Abstract
Context: Atrial natriuretic peptide (ANP) in pharmacological concentrations stimulates lipid mobilization in humans.
Objective: The objective was to determine the hemodynamic and metabolic response to physiologically relevant ANP concentrations.
Design: The design was a human physiological study, conducted in 2004.
Setting: The study was conducted at an academic research institute.
Participants: Fourteen healthy normal-weight men (30 +/- 1.2 yr) participated in the study.
Intervention: Intravenous infusion of human ANP (h-ANP) was administered at rates of 6.25, 12.5, and 25 ng/kg.min.
Main outcome measures: We studied local changes in blood flow and glucose and lipid metabolism of abdominal sc adipose tissue and femoral skeletal muscle by microdialysis. Overall changes in energy expenditure and substrate oxidation rates were monitored by indirect calorimetry.
Results: The increase in serum nonesterified fatty acids and glycerol concentrations were correlated with ANP plasma concentrations (r(2) = 0.86 and r(2) = 0.76, respectively). In adipose tissue, glycerol increased from 53 +/- 6 micromol/liter to 87+/-13 micromol/liter (P < 0.001). In femoral skeletal muscle, glycerol concentrations did not change, whereas lactate-to-pyruvate ratio decreased from 91 +/- 23 to 32 +/- 4 (P < 0.001). Indirect calorimetry indicated an increase in lipid oxidation (P < 0.05) concomitantly with a decrease in carbohydrate oxidation (P < 0.01), without changes in overall energy expenditure.
Conclusions: ANP briskly stimulates lipid mobilization and oxidation at plasma concentrations that are encountered in conditions such as heart failure. Natriuretic-peptide induced lipid mobilization might contribute to cardiac cachexia. Drugs that interfere with the natriuretic peptide system should be evaluated for potential metabolic side effects.
Similar articles
-
Beta-adrenergic and atrial natriuretic peptide interactions on human cardiovascular and metabolic regulation.J Clin Endocrinol Metab. 2006 Dec;91(12):5069-75. doi: 10.1210/jc.2006-1084. Epub 2006 Sep 19. J Clin Endocrinol Metab. 2006. PMID: 16984990 Free PMC article.
-
Atrial natriuretic peptide induces postprandial lipid oxidation in humans.Diabetes. 2008 Dec;57(12):3199-204. doi: 10.2337/db08-0649. Epub 2008 Oct 3. Diabetes. 2008. PMID: 18835931 Free PMC article.
-
Atrial natriuretic peptide contributes to physiological control of lipid mobilization in humans.FASEB J. 2004 May;18(7):908-10. doi: 10.1096/fj.03-1086fje. Epub 2004 Mar 19. FASEB J. 2004. PMID: 15033935 Clinical Trial.
-
[Physiological and pathophysiological features of the control of lipolysis and lipid mobilization by natriuretic peptides].J Soc Biol. 2006;200(1):67-76. doi: 10.1051/jbio:2006009. J Soc Biol. 2006. PMID: 17144164 Review. French.
-
[Natriuretic peptides: a new lipolytic pathway in human fat cells].Med Sci (Paris). 2005 Dec;21 Spec No:29-33. Med Sci (Paris). 2005. PMID: 16598902 Review. French.
Cited by
-
MANP in Hypertension With Metabolic Syndrome: Proof-of-Concept Study of Natriuretic Peptide-Based Therapy for Cardiometabolic Disease.JACC Basic Transl Sci. 2023 Nov 1;9(1):18-29. doi: 10.1016/j.jacbts.2023.08.011. eCollection 2024 Jan. JACC Basic Transl Sci. 2023. PMID: 38362338 Free PMC article.
-
Atrial natriuretic peptide and leptin interactions in healthy men.Front Endocrinol (Lausanne). 2023 Jun 30;14:1195677. doi: 10.3389/fendo.2023.1195677. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37455918 Free PMC article. Clinical Trial.
-
Case report: Mutation in NPPA gene as a cause of fibrotic atrial myopathy.Front Cardiovasc Med. 2023 Jun 8;10:1149717. doi: 10.3389/fcvm.2023.1149717. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37363091 Free PMC article.
-
Effects of Angiotensin Receptor-Neprilysin Inhibitors (ARNIs) on the Glucose and Fat Metabolism Biomarkers Leptin and Fructosamine.J Clin Med. 2023 Apr 24;12(9):3083. doi: 10.3390/jcm12093083. J Clin Med. 2023. PMID: 37176525 Free PMC article.
-
Water Consumption: Effect on Energy Expenditure and Body Weight Management.Curr Obes Rep. 2023 Jun;12(2):99-107. doi: 10.1007/s13679-023-00501-8. Epub 2023 Apr 10. Curr Obes Rep. 2023. PMID: 37036559 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases